Rachel Rice

3.5k total citations · 2 hit papers
22 papers, 2.4k citations indexed

About

Rachel Rice is a scholar working on Molecular Biology, Oncology and Spectroscopy. According to data from OpenAlex, Rachel Rice has authored 22 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Spectroscopy. Recurrent topics in Rachel Rice's work include Glycosylation and Glycoproteins Research (8 papers), Advanced Proteomics Techniques and Applications (6 papers) and vaccines and immunoinformatics approaches (5 papers). Rachel Rice is often cited by papers focused on Glycosylation and Glycoproteins Research (8 papers), Advanced Proteomics Techniques and Applications (6 papers) and vaccines and immunoinformatics approaches (5 papers). Rachel Rice collaborates with scholars based in United States, Australia and Switzerland. Rachel Rice's co-authors include Brian L. West, Kim N. Green, Allison R. Najafi, Elizabeth E. Spangenberg, Monica R. P. Elmore, Nabil N. Dagher, Hoa Nguyen, Masashi Kitazawa, Maya A. Koike and Bernice Matusow and has published in prestigious journals such as Neuron, Journal of Clinical Oncology and Journal of Neuroscience.

In The Last Decade

Rachel Rice

21 papers receiving 2.4k citations

Hit Papers

Colony-Stimulating Factor 1 Receptor Signaling Is Necessa... 2014 2026 2018 2022 2014 2016 400 800 1.2k

Peers

Rachel Rice
Allison R. Najafi United States
Samuel E. Marsh United States
Zain Fanek United States
Inge R. Holtman Netherlands
Arnaud Frouin United States
Adrián Olmos‐Alonso United Kingdom
Kelly R. Miller United States
Marta Olah United States
Allison R. Najafi United States
Rachel Rice
Citations per year, relative to Rachel Rice Rachel Rice (= 1×) peers Allison R. Najafi

Countries citing papers authored by Rachel Rice

Since Specialization
Citations

This map shows the geographic impact of Rachel Rice's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel Rice with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel Rice more than expected).

Fields of papers citing papers by Rachel Rice

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel Rice. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel Rice. The network helps show where Rachel Rice may publish in the future.

Co-authorship network of co-authors of Rachel Rice

This figure shows the co-authorship network connecting the top 25 collaborators of Rachel Rice. A scholar is included among the top collaborators of Rachel Rice based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel Rice. Rachel Rice is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dhar, Chirag, Prasanna Ramachandran, Gege Xu, et al.. (2024). Diagnosing and staging epithelial ovarian cancer by serum glycoproteomic profiling. British Journal of Cancer. 130(10). 1716–1724. 5 indexed citations
2.
Čaval, Tomislav, Gege Xu, Chih‐Wei Chu, et al.. (2024). Mass Spectrometry Analysis of Glycopeptides Enriched by Anion Exchange-Mediated Methods Reveals PolyLacNAc-Extended N-Glycans in Integrins and Tetraspanins in Melanoma Cells. Analytical Chemistry. 96(13). 5086–5094. 4 indexed citations
3.
Xu, Gege, Rachel Rice, Yana G. Najjar, et al.. (2023). Plasma glycoproteomic biomarkers identify metastatic melanoma patients with reduced clinical benefit from immune checkpoint inhibitor therapy. Frontiers in Immunology. 14. 1187332–1187332. 9 indexed citations
4.
5.
Ramachandran, Prasanna, Gege Xu, Hector H. Huang, et al.. (2022). Serum Glycoprotein Markers in Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma. Journal of Proteome Research. 21(4). 1083–1094. 22 indexed citations
6.
Xu, Gege, et al.. (2022). Liquid-biopsy-derived glycoproteomic profiling as a novel means for noninvasive diagnosis of ovarian cancer.. Journal of Clinical Oncology. 40(16_suppl). e17604–e17604. 2 indexed citations
7.
Xu, Gege, et al.. (2022). Glycoproteomics as a powerful liquid biopsy-based screening tool for non-small cell lung cancer.. Journal of Clinical Oncology. 40(16_suppl). e21148–e21148. 5 indexed citations
8.
Zhou, Bo, Gege Xu, Rachel Rice, et al.. (2022). Differential Peripheral Blood Glycoprotein Profiles in Symptomatic and Asymptomatic COVID-19. Viruses. 14(3). 553–553. 7 indexed citations
9.
Lindpaintner, Klaus, Gege Xu, Rachel Rice, et al.. (2022). Glycoproteomics as a powerful liquid biopsy-based predictor of checkpoint inhibitor treatment benefit in metastatic malignant melanoma.. Journal of Clinical Oncology. 40(16_suppl). 9545–9545. 4 indexed citations
10.
Xu, Gege, et al.. (2022). Predicting breast cancer in women using liquid biopsy-derived glycoproteomic markers.. Journal of Clinical Oncology. 40(16_suppl). e12545–e12545. 1 indexed citations
11.
Xu, Gege, Rachel Rice, Hector H. Huang, et al.. (2021). Abstract 387: Glycoproteomics as a powerful liquid biopsy-based predictor of checkpoint-inhibitor treatment response. Cancer Research. 81(13_Supplement). 387–387. 2 indexed citations
12.
Lindpaintner, Klaus, Michael L. Cheng, Jillian M. Prendergast, et al.. (2021). 30 Blood-based glycoprotein signatures in advanced non-small-cell lung carcinoma (NSCLC) receiving first-line immune checkpoint blockade. Journal for ImmunoTherapy of Cancer. 9(Suppl 2). A35–A35. 3 indexed citations
13.
Rice, Rachel, et al.. (2017). Microglial repopulation resolves inflammation and promotes brain recovery after injury. Glia. 65(6). 931–944. 176 indexed citations
14.
Spangenberg, Elizabeth E., Allison R. Najafi, Rachel Rice, et al.. (2016). Eliminating microglia in Alzheimer’s mice prevents neuronal loss without modulating amyloid-β pathology. Brain. 139(4). 1265–1281. 514 indexed citations breakdown →
15.
Rice, Rachel, et al.. (2015). Elimination of Microglia Improves Functional Outcomes Following Extensive Neuronal Loss in the Hippocampus. Journal of Neuroscience. 35(27). 9977–9989. 191 indexed citations
16.
Elmore, Monica R. P., Allison R. Najafi, Maya A. Koike, et al.. (2014). Colony-Stimulating Factor 1 Receptor Signaling Is Necessary for Microglia Viability, Unmasking a Microglia Progenitor Cell in the Adult Brain. Neuron. 82(2). 380–397. 1369 indexed citations breakdown →
17.
Rice, Rachel, Nicole C. Berchtold, Carl W. Cotman, & Kim N. Green. (2013). Age-related downregulation of the CaV3.1 T-type calcium channel as a mediator of amyloid beta production. Neurobiology of Aging. 35(5). 1002–1011. 43 indexed citations
18.
Wood, Ruth I. & Rachel Rice. (2013). Ethanol-induced conditioned partner preference in female mice. Behavioural Brain Research. 243. 273–277. 7 indexed citations
19.
Drygin, Denis, Caroline B. Ho, Mayuko Omori, et al.. (2011). Protein kinase CK2 modulates IL-6 expression in inflammatory breast cancer. Biochemical and Biophysical Research Communications. 415(1). 163–167. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026